"Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial" by Philip J. Mease

Article

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial

Arthritis & Rheumatism (2019)

Philip J. Mease, University of Washington
Dafna D. Gladman, University of Toronto
David H. Collier, Amgen
Christopher T. Ritchlin, University of Rochester Medical Center
Philip S. Helliwell, University of Leeds
Lyrica Liu, Amgen
Gregory Kricorian, Amgen
James B. Chung, Amgen

Link

Disciplines

Dermatology,
Medicine and Health Sciences,
Endocrinology, Diabetes, and Metabolism and
Immunology and Infectious Disease

Publication Date

February 12, 2019

DOI

10.1002/art.40851

Citation Information

Philip J. Mease, Dafna D. Gladman, David H. Collier, Christopher T. Ritchlin, et al.. "Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial" Arthritis & Rheumatism (2019)
Available at: http://works.bepress.com/philip-mease/310/